DV
Dividend Vision

QTRX — Quanterix Corp

Quanterix Corp (QTRX)

Total return is -85.2% over the past 8.7 years, 321.8 points behind SPY at 236.6%. Its deepest 1-year drawdown was 70.0%.

Quanterix Corporation is a life sciences company that develops protein detection instruments and assays for research and clinical applications, primarily serving academic institutions, pharmaceutical companies, and contract research organizations in neurology, oncology, immunology, and inflammation research. The company does not currently distribute dividends. Quanterix appeals to growth-oriented investors seeking exposure to the life sciences research tools sector rather than income investors.

QTRX key facts

Asset type
Stock
Asset class
Equity
Inception date
12/07/2017
Last close
$2.59
Market cap
$183,713,328
Average volume
838400.0
Beta
1.038
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.37